查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401002

聚乙二醇化蛋白质市场，按蛋白质类型、按应用、最终用途、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

PEGylated Proteins Market, By Protein Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 282 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年聚乙二醇化蛋白质市场规模为 144.243 亿美元，2023 年至 2030 年复合CAGR为 4.7%。

聚乙二醇化蛋白质市场-市场动态

提高生物药物治疗疗效和病患体验的需求推动市场需求

聚乙二醇化具有多种优点，包括增加药物在体内的循环、降低免疫原性和提高稳定性。这样可以减少用药频率，从而可以提高患者的依从性并减轻慢性病护理的负担。此外，聚乙二醇化有可能减少副作用和不良反应，使生物製剂对患者更耐受、更安全。因此，製药公司和学术界正在继续研究聚乙二醇化作为优化当前生物製剂和开发创新疗法的技术，其目标是最终改善医疗保健结果。

聚乙二醇化蛋白质市场 - 关键见解

根据我们的研究分析师分享的分析，全球聚乙二醇化蛋白质市场预计在预测期内（2023-2030 年）每年将以 4.7% 左右的CAGR成长

由于需要提高生物药物治疗的疗效和患者体验，聚乙二醇化蛋白质产业预计将以显着的速度成长。

根据蛋白质类型细分，集落刺激因子预计将在 2022 年显示最大的市场份额

根据应用细分，自体免疫疾病是 2022 年领先的蛋白质类型

按地区划分，北美是 2022 年的主要收入来源

聚乙二醇化蛋白质市场区隔分析：

全球聚乙二醇化蛋白质市场根据蛋白质类型、应用、最终用途和地区进行细分。

根据蛋白质类型，市场分为四类：集落刺激因子、干扰素、促红血球生成素和其他。集落刺激因子主导市场。聚乙二醇化蛋白质，尤其是聚乙二醇化集落刺激因子，由于其在各种医学应用中的用途而受到很高的需求。集落刺激因子可增加血球的产生，通常经过聚乙二醇化，以提高其对癌症、贫血和免疫缺陷等疾病的治疗效果。

依应用市场分为三类：癌症、自体免疫疾病、肝炎、多发性硬化症、血友病、胃肠道疾病和其他。自体免疫疾病领域在市场中占据主导地位，并可能在预测期内保持其主导地位。聚乙二醇化蛋白在自体免疫疾病的应用需求量很大。这些生物製剂可以透过使用聚乙二醇（PEG）来改变自体免疫相关蛋白来调节免疫反应和降低炎症，从而延长半衰期并提高治疗类风湿性关节炎、多发性硬化症和狼疮等疾病的功效。

聚乙二醇化蛋白质市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。有几个变数影响北美聚乙二醇化蛋白质的市场。该地区拥有完善的製药和生物技术部门，致力于创新生物药物的开发和商业化。此外，癌症、自体免疫疾病和血液疾病等慢性疾病的发生率不断增加，也增加了对客製化生物疗法的需求。此外，北美的监管框架促进了创新药物配方的创新和开发，例如聚乙二醇化蛋白，可提高治疗效果和患者依从性。最后，该地区强大的医疗基础设施和尖端疗法的可用性使其成为聚乙二醇化蛋白质疗法的良好市场，推动了该领域的持续研究和投资。

聚乙二醇化蛋白质市场-竞争格局：

聚乙二醇化蛋白质的竞争环境是动态且多元的。罗氏、安进和诺和诺德等领先的製药和生物技术公司在单株抗体和细胞因子等聚乙二醇化生物製剂的开发上进行了大量投资。然而，该领域也有创意新创公司和专业生物技术公司，例如仅专注于聚乙二醇化技术的 Nektar Therapeutics。这种多样性鼓励创新和竞争力，推动药物传递的突破并提高生物製剂的治疗效果。随着对重点和持久生物药物的需求不断发展，竞争环境不断变化，重点是生产更有效和对患者友好的聚乙二醇化蛋白疗法。

目录

第 1 章：聚乙二醇化蛋白质市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按蛋白质类型分類的聚乙二醇化蛋白质市场片段
    • 聚乙二醇化蛋白质市场片段（依应用）
    • 依最终用途分類的聚乙二醇化蛋白质市场片段
    • 按国家/地区分類的聚乙二醇化蛋白质市场片段
    • 按地区分類的聚乙二醇化蛋白质市场片段
  • 竞争洞察

第 3 章：聚乙二醇化蛋白质主要市场趋势

  • 聚乙二醇化蛋白质市场驱动因素
    • 市场驱动因素的影响分析
  • 聚乙二醇化蛋白质市场限制
    • 市场限制影响分析
  • 聚乙二醇化蛋白质市场机会
  • 聚乙二醇化蛋白质市场未来趋势

第 4 章：聚乙二醇化蛋白质产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：聚乙二醇化蛋白质市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：聚乙二醇化蛋白质市场格局

  • 2022 年聚乙二醇化蛋白质市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：聚乙二醇化蛋白质市场 - 依蛋白质类型

  • 概述
    • 按蛋白质类型分類的细分市场份额分析
    • 集落刺激因子
    • 干扰素
    • 促红血球生成素
    • 其他的

第 8 章：聚乙二醇化蛋白质市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 癌症
    • 自体免疫疾病
    • 肝炎
    • 多发性硬化症
    • 血友病
    • 胃肠道疾病
    • 其他的

第 9 章：聚乙二醇化蛋白质市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 製药与生物技术公司
    • 合约研究组织
    • 学术及研究机构

第 10 章：聚乙二醇化蛋白质市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 聚乙二醇化蛋白质北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按蛋白质类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 聚乙二醇化蛋白质欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按蛋白质类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 聚乙二醇化蛋白质亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按蛋白质类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用途）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲聚乙二醇化蛋白质主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按蛋白质类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲的聚乙二醇化蛋白质主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按蛋白质类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 聚乙二醇化蛋白质产业

  • 竞争仪表板
  • 公司简介
    • Biogen Inc
    • Pfizer Inc
    • UCB SA
    • Leadiant Biosciences, Inc.
    • Amgen Inc.
    • Thermo Fisher Scientific Inc.
    • Horizon Therapeutics Plc.
    • Novo Nordisk A/S
    • F. Hoffmann-La Roche AG
    • Bayer AG
    • BioMarin
    • RedHill Biopharma Ltd.
    • Profacgen
    • Creative PEGworks
    • NOF America Corp.
    • Aurigene Pharmaceutical Services Ltd.
    • Laysan Bio, Inc.

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1966

REPORT HIGHLIGHT

PEGylated Proteins Market size was valued at USD 14,424.3 Million in 2022, expanding at a CAGR of 4.7 % from 2023 to 2030.

Therapeutic biologics or molecules that were chemically changed by the addition of polyethylene glycol (PEG) chains are referred to as PEGylated proteins. This change is intended to improve the biologic's pharmacokinetic features, such as enhanced stability, longer bloodstream circulation duration, and decreased immunogenicity. PEGylation increases medication bioavailability, allowing for less frequent dosage and perhaps decreasing adverse effects. This technology is frequently utilized in the pharmaceutical industry to enhance the therapeutic profile of different biologics, such as proteins and peptides, making them more successful in the treatment of a variety of medical disorders such as cancer, autoimmune diseases, and hemophilia.

PEGylated Proteins Market- Market Dynamics

The need to enhance the therapeutic efficacy and patient experience in biologic drug treatments propel market demand

PEGylation has various benefits, including increased medication circulation throughout the body, less immunogenicity, and greater stability. This enables less frequent dosage, which may improve patient compliance and reduce the burden of chronic illness care. Furthermore, PEGylation has the potential to reduce side effects and adverse responses, making biologics more bearable and safer for patients. As a consequence, pharmaceutical firms and academics are continuing to investigate PEGylation as a technique for optimizing current biologics and developing innovative therapies, with the goal of eventually improving healthcare outcomes.

PEGylated Proteins Market- Key Insights

As per the analysis shared by our research analyst, the global PEGylated Proteins market is estimated to grow annually at a CAGR of around 4.7% over the forecast period (2023-2030)

The PEGylated Proteins industry is projected to grow at a significant rate due to the need to enhance the therapeutic efficacy and patient experience in biologic drug treatments.

Based on Protein Type segmentation, Colony-stimulating Factors was predicted to show maximum market share in the year 2022

Based on Application segmentation, Autoimmune Diseases was the leading Protein Type in 2022

On the basis of region, North America was the leading revenue generator in 2022

PEGylated Proteins Market- Segmentation Analysis:

The Global PEGylated Proteins Market is segmented on the basis of Protein Type, Application, End-Use, and Region.

The market is divided into four categories based on Protein Type: Colony-stimulating Factors, Interferons, Erythropoietin, and Others. The Colony-stimulating Factors dominates the market. PEGylated proteins, especially PEGylated colony-stimulating factors, are in high demand due to their usage in a variety of medicinal applications. Colony-stimulating factors, which increase the creation of blood cells, are often PEGylated to improve their therapeutic effectiveness in illnesses such as cancer, anaemia, and immunodeficiency disorders.

The market is divided into three categories based on Application: Cancer, Autoimmune Diseases, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorders, and Others. The Autoimmune Diseases sector dominates the market and is likely to maintain its dominance during the forecast period. PEGylated proteins are in high demand for use in autoimmune disorders. These biologics may provide prolonged half-lives and enhanced efficacy in treating illnesses such as rheumatoid arthritis, multiple sclerosis, and lupus by modulating immune responses and lowering inflammation by altering autoimmune-related proteins using polyethylene glycol (PEG).

PEGylated Proteins Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several variables influence the market for PEGylated proteins in North America. The area boasts a well-established pharmaceutical and biotechnology sector devoted to the development and commercialization of innovative biologic medicines. Additionally, the increasing frequency of chronic illnesses such as cancer, autoimmune disorders, and blood disorders has boosted the need for tailored biologic therapies. Furthermore, the regulatory framework in North America fosters innovation and the development of innovative medicine formulations, such as PEGylated proteins, which enhance treatment results and patient compliance. Finally, the region's strong healthcare infrastructure and availability of cutting-edge therapies make it a good market for PEGylated protein therapeutics, fueling continuous research and investment in this sector.

PEGylated Proteins Market- Competitive Landscape:

The competitive environment for PEGylated proteins is dynamic and varied. Leading pharmaceutical and biotechnology firms such as Roche, Amgen, and Novo Nordisk have made significant investments in the development of PEGylated biologics such as monoclonal antibodies and cytokines. However, there are also creative startups and specialized biotech corporations in the sector, such as Nektar Therapeutics, which focuses only on PEGylation technology. This variety encourages innovation and competitiveness, pushing for breakthroughs in drug delivery and increasing biologics' therapeutic profile. The competitive environment continues to change as the need for focused and long-lasting biologic medicines develops, with an emphasis on producing more effective and patient-friendly PEGylated protein therapeutics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PEGYLATED PROTEINS MARKET KEY PLAYERS

  • Biogen Inc
  • Pfizer Inc
  • UCB S.A.
  • Leadiant Biosciences, Inc.
  • Amgen Inc.
  • Thermo Fisher Scientific Inc.
  • Horizon Therapeutics Plc.
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche AG
  • Bayer AG
  • BioMarin
  • RedHill Biopharma Ltd.
  • Profacgen
  • Creative PEGworks
  • NOF America Corp.
  • Aurigene Pharmaceutical Services Ltd.
  • Laysan Bio, Inc.

GLOBAL PEGYLATED PROTEINS MARKET, BY PROTEIN TYPE

  • Colony-stimulating Factors
  • Interferons
  • Erythropoietin
  • Others

GLOBAL PEGYLATED PROTEINS MARKET, BY APPLICATION

  • Cancer
  • Autoimmune Diseases
  • Hepatitis
  • Multiple Sclerosis
  • Hemophilia
  • Gastrointestinal Disorders
  • Others

GLOBAL PEGYLATED PROTEINS MARKET, BY END-USE

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic & Research Institutes

GLOBAL PEGYLATED PROTEINS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. PEGylated Proteins Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. PEGylated Proteins Market Snippet by Protein Type
    • 2.1.2. PEGylated Proteins Market Snippet by Application
    • 2.1.3. PEGylated Proteins Market Snippet by End-Use
    • 2.1.4. PEGylated Proteins Market Snippet by Country
    • 2.1.5. PEGylated Proteins Market Snippet by Region
  • 2.2. Competitive Insights

3. PEGylated Proteins Key Market Trends

  • 3.1. PEGylated Proteins Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. PEGylated Proteins Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. PEGylated Proteins Market Opportunities
  • 3.4. PEGylated Proteins Market Future Trends

4. PEGylated Proteins Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. PEGylated Proteins Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. PEGylated Proteins Market Landscape

  • 6.1. PEGylated Proteins Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. PEGylated Proteins Market - By Protein Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Protein Type, 2022 & 2030 (%)
    • 7.1.2. Colony-stimulating Factors
    • 7.1.3. Interferons
    • 7.1.4. Erythropoietin
    • 7.1.5. Others

8. PEGylated Proteins Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Cancer
    • 8.1.3. Autoimmune Diseases
    • 8.1.4. Hepatitis
    • 8.1.5. Multiple Sclerosis
    • 8.1.6. Hemophilia
    • 8.1.7. Gastrointestinal Disorders
    • 8.1.8. Others

9. PEGylated Proteins Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical & Biotechnology Companies
    • 9.1.3. Contract Research Organizations
    • 9.1.4. Academic & Research Institutes

10. PEGylated Proteins Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. PEGylated Proteins Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. PEGylated Proteins Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. PEGylated Proteins Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. PEGylated Proteins Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. PEGylated Proteins Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- PEGylated Proteins Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Biogen Inc
    • 11.2.2. Pfizer Inc
    • 11.2.3. UCB S.A.
    • 11.2.4. Leadiant Biosciences, Inc.
    • 11.2.5. Amgen Inc.
    • 11.2.6. Thermo Fisher Scientific Inc.
    • 11.2.7. Horizon Therapeutics Plc.
    • 11.2.8. Novo Nordisk A/S
    • 11.2.9. F. Hoffmann-La Roche AG
    • 11.2.10. Bayer AG
    • 11.2.11. BioMarin
    • 11.2.12. RedHill Biopharma Ltd.
    • 11.2.13. Profacgen
    • 11.2.14. Creative PEGworks
    • 11.2.15. NOF America Corp.
    • 11.2.16. Aurigene Pharmaceutical Services Ltd.
    • 11.2.17. Laysan Bio, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Applications
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE PEGylated Proteins Market: Protein Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Protein Type
  • TABLE Global PEGylated Proteins Market, by Protein Type 2018-2030 (USD Million)
  • TABLE PEGylated Proteins Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global PEGylated Proteins Market, by Application 2018-2030 (USD Million)
  • TABLE PEGylated Proteins Market: End-Use Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global PEGylated Proteins Market, by End-Use 2018-2030 (USD Million)
  • TABLE PEGylated Proteins Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global PEGylated Proteins Market, by Region 2018-2030 (USD Million)
  • TABLE North America PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE North America PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE North America PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE North America PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)
  • TABLE Europe PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE Europe PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)
  • TABLE Asia Pacific PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)
  • TABLE Latin America PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE Latin America PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)
  • TABLE Middle East and Africa PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)

List of Figures

  • FIGURE PEGylated Proteins Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Protein Type segment market share analysis, 2022 & 2030
  • FIGURE Protein Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-Use segment market share analysis, 2022 & 2030
  • FIGURE End-Use segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America PEGylated Proteins Market share and leading players, 2022
  • FIGURE Europe PEGylated Proteins Market share and leading players, 2022
  • FIGURE Asia Pacific PEGylated Proteins Market share and leading players, 2022
  • FIGURE Latin America PEGylated Proteins Market share and leading players, 2022
  • FIGURE Middle East and Africa PEGylated Proteins Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe PEGylated Proteins Market share analysis by country, 2022
  • FIGURE Germany PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific PEGylated Proteins Market share analysis by country, 2022
  • FIGURE India PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America PEGylated Proteins Market share analysis by country, 2022
  • FIGURE Brazil PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa PEGylated Proteins Market share analysis by country, 2022
  • FIGURE Saudi Arabia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)